Site initiation completed for first study ever to evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with.
Carlsbad, CA, Feb. 15, 2024 Palisade Bio, Inc. , a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal diseases, today announced that its.
Palisade Bio To Present At Digestive Disease Week (DDW) 2024 menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
EDMONTON, Alberta, Feb. 15, 2024 Ceapro Inc. is pleased to announce that it has mailed and filed a management information circular dated February 9, 2024 and related meeting materials for.